Sastasundar Ventures Limited
Sastasundar Ventures Limited operates a digital network of healthcare and portfolio management services in India. The company operates through the Financial Services and Healthcare Network segments. It is involved in the financing of loans; investment in shares and securities; and activities for pathology and marketing of healthcare and OTC products through e-commerce portal. The company also pro… Read more
Sastasundar Ventures Limited (SASTASUNDR) - Net Assets
Latest net assets as of September 2025: ₹8.76 Billion INR
Based on the latest financial reports, Sastasundar Ventures Limited (SASTASUNDR) has net assets worth ₹8.76 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹10.08 Billion) and total liabilities (₹1.32 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹8.76 Billion |
| % of Total Assets | 86.93% |
| Annual Growth Rate | 21.8% |
| 5-Year Change | 276.91% |
| 10-Year Change | 295.83% |
| Growth Volatility | 109.45 |
Sastasundar Ventures Limited - Net Assets Trend (2007–2025)
This chart illustrates how Sastasundar Ventures Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sastasundar Ventures Limited (2007–2025)
The table below shows the annual net assets of Sastasundar Ventures Limited from 2007 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹8.65 Billion | -13.51% |
| 2024-03-31 | ₹10.00 Billion | +0.60% |
| 2023-03-31 | ₹9.94 Billion | -17.72% |
| 2022-03-31 | ₹12.07 Billion | +426.43% |
| 2021-03-31 | ₹2.29 Billion | -6.84% |
| 2020-03-31 | ₹2.46 Billion | +23.15% |
| 2019-03-31 | ₹2.00 Billion | -1.69% |
| 2018-03-31 | ₹2.03 Billion | +4.09% |
| 2017-03-31 | ₹1.95 Billion | -10.55% |
| 2016-03-31 | ₹2.18 Billion | -14.34% |
| 2015-03-31 | ₹2.55 Billion | -5.65% |
| 2014-03-31 | ₹2.70 Billion | -2.29% |
| 2013-03-31 | ₹2.77 Billion | +3.10% |
| 2012-03-31 | ₹2.68 Billion | +4.01% |
| 2011-03-31 | ₹2.58 Billion | +178.82% |
| 2010-03-31 | ₹925.05 Million | +18.08% |
| 2009-03-31 | ₹783.38 Million | +11.17% |
| 2008-03-31 | ₹704.70 Million | +183.69% |
| 2007-03-31 | ₹248.41 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sastasundar Ventures Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 365852600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹3.66 Billion | 54.62% |
| Common Stock | ₹318.11 Million | 4.75% |
| Other Comprehensive Income | ₹1.33 Billion | 19.89% |
| Other Components | ₹1.39 Billion | 20.75% |
| Total Equity | ₹6.70 Billion | 100.00% |
Sastasundar Ventures Limited Competitors by Market Cap
The table below lists competitors of Sastasundar Ventures Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xin Chio Global Co Ltd
TWO:3171
|
$19.67 Million |
|
COLUMBUS ENERGY S.A. ZY 7
F:0Q8
|
$19.68 Million |
|
Actoz Soft Co.Ltd
KQ:052790
|
$19.68 Million |
|
EnWave Corporation
PINK:NWVCF
|
$19.70 Million |
|
Jameson Resources Ltd
AU:JAL
|
$19.66 Million |
|
Intergis
KO:129260
|
$19.64 Million |
|
Aytu BioScience Inc
NASDAQ:AYTU
|
$19.64 Million |
|
Venator Materials PLC
PINK:VNTRF
|
$19.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sastasundar Ventures Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,623,745,000 to 6,698,710,000, a change of -925,035,000 (-12.1%).
- Net loss of 911,671,000 reduced equity.
- Other comprehensive income decreased equity by 8,663,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹-911.67 Million | -13.61% |
| Other Comprehensive Income | ₹-8.66 Million | -0.13% |
| Other Changes | ₹-4.70 Million | -0.07% |
| Total Change | ₹- | -12.13% |
Book Value vs Market Value Analysis
This analysis compares Sastasundar Ventures Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.37x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.19x to 1.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-03-31 | ₹15.82 | ₹287.75 | x |
| 2008-03-31 | ₹41.80 | ₹287.75 | x |
| 2009-03-31 | ₹38.57 | ₹287.75 | x |
| 2010-03-31 | ₹47.61 | ₹287.75 | x |
| 2011-03-31 | ₹81.08 | ₹287.75 | x |
| 2012-03-31 | ₹84.33 | ₹287.75 | x |
| 2013-03-31 | ₹86.91 | ₹287.75 | x |
| 2014-03-31 | ₹84.87 | ₹287.75 | x |
| 2015-03-31 | ₹80.05 | ₹287.75 | x |
| 2016-03-31 | ₹68.54 | ₹287.75 | x |
| 2017-03-31 | ₹61.28 | ₹287.75 | x |
| 2018-03-31 | ₹55.15 | ₹287.75 | x |
| 2019-03-31 | ₹44.66 | ₹287.75 | x |
| 2020-03-31 | ₹66.05 | ₹287.75 | x |
| 2021-03-31 | ₹62.84 | ₹287.75 | x |
| 2022-03-31 | ₹285.50 | ₹287.75 | x |
| 2023-03-31 | ₹236.84 | ₹287.75 | x |
| 2024-03-31 | ₹239.66 | ₹287.75 | x |
| 2025-03-31 | ₹210.59 | ₹287.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sastasundar Ventures Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.61%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.37%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 1.45x
- Recent ROE (-13.61%) is below the historical average (3.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 30.73% | 41.19% | 0.49x | 1.53x | ₹51.50 Million |
| 2008 | 25.99% | 44.98% | 0.37x | 1.56x | ₹112.65 Million |
| 2009 | 10.05% | 21.76% | 0.37x | 1.24x | ₹423.10K |
| 2010 | 26.32% | 42.55% | 0.48x | 1.28x | ₹150.98 Million |
| 2011 | 12.71% | 41.76% | 0.27x | 1.12x | ₹69.88 Million |
| 2012 | 5.23% | 24.26% | 0.18x | 1.18x | ₹-127.89 Million |
| 2013 | 2.96% | 17.32% | 0.15x | 1.14x | ₹-194.50 Million |
| 2014 | -2.40% | -24.21% | 0.09x | 1.14x | ₹-334.73 Million |
| 2015 | -5.85% | -30.83% | 0.17x | 1.10x | ₹-403.67 Million |
| 2016 | -16.79% | -42.45% | 0.34x | 1.18x | ₹-584.11 Million |
| 2017 | -14.68% | -21.54% | 0.53x | 1.29x | ₹-481.20 Million |
| 2018 | -6.77% | -7.46% | 0.68x | 1.34x | ₹-294.25 Million |
| 2019 | -26.43% | -17.18% | 0.96x | 1.60x | ₹-517.65 Million |
| 2020 | -18.46% | -10.07% | 1.22x | 1.50x | ₹-598.07 Million |
| 2021 | -5.20% | -1.91% | 1.86x | 1.46x | ₹-303.90 Million |
| 2022 | 69.02% | 99.52% | 0.49x | 1.41x | ₹5.36 Billion |
| 2023 | -9.58% | -6.96% | 0.86x | 1.60x | ₹-1.48 Billion |
| 2024 | 1.17% | 0.66% | 1.18x | 1.51x | ₹-673.55 Million |
| 2025 | -13.61% | -8.37% | 1.12x | 1.45x | ₹-1.58 Billion |
Industry Comparison
This section compares Sastasundar Ventures Limited's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $14,172,530,000
- Average return on equity (ROE) among peers: 6.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sastasundar Ventures Limited (SASTASUNDR) | ₹8.76 Billion | 30.73% | 0.15x | $19.66 Million |
| Medplus Health Services Limited (MEDPLUS) | $14.17 Billion | 6.76% | 0.83x | $659.03 Million |